FDA's Pelvic Mesh Scrutiny May Have Limited Impact In MDL
The U.S. Food and Drug Administration's view that certain transvaginal meshes are now high-risk medical devices that must meet strict safety assessments appears to support mesh implant patients in federal multidistrict...To view the full article, register now.
Already a subscriber? Click here to view full article